Well-known focused ultrasound researcher Nathan McDannold, PhD, of Harvard Medical School, is scheduled to discuss the use of MR-guided focused ultrasound in delivering cancer drugs across the blood-brain barrier at the Society of Neuro-Oncology Annual Meeting, scheduled for November 17-20 in Orange County, California. This year’s meeting is being held in conjunction with the AANS/CNS Section on Tumors.
McDannold’s talk, entitled, “MRgFUS induced blood brain barrier disruption and novel drug delivery for brain tumors,” is scheduled for presentation during the society’s Education Day on November 17.
“This is the first time that SNO has included a discussion about MRgFUS in its annual meeting,”said Jason Sheehan, MD a neurosurgeon who is co-chair of Education Day and co-director of the Focused Ultrasound Center at the University of Virginia. ”We’re hoping that this will help educate participants about the emerging role of MR-guided FUS in neuro-oncology.”